Novartis Looks to Buy French Firm to Bolster Cancer Portfolio

The $3.9 billion acquisition of Advanced Accelerator Applications would mark a rare deal in the pharmaceutical sector this year.

Source: NYT Health - October 30, 2017 Category: Consumer Health News Authors: CHAD BRAY Tags: Mergers, Acquisitions and Divestitures Drugs (Pharmaceuticals) Cancer Novartis AG Source Type: news